News | January 09, 2015

CHI Franciscan Health Designated As The First Northwest Accredited Heart Failure System

Healthcare Colloquium was chosen as accreditation body because of framework that enables standardized best practices and coordination of care

heart Failure, CHI Franciscan, Healthcare Colloquium

Image courtesy of PR Newswire


January 9, 2015 — The Healthcare Colloquium announced that CHI Franciscan Health is the first Accredited Heart Failure System in the Northwest.

St. Joseph Medical Center earned recognition as an Accredited Heart Failure Institute.

St. Elizabeth Hospital, St. Francis Hospital, St. Clare Hospital, St. Anthony Hospital and Harrison Medical Center became Accredited Heart Failure Centers.  CHI Franciscan Health is the third Accredited Heart Failure system through The Healthcare Colloquium.

The Healthcare Colloquium's unique heart failure accreditation process builds on the member hospital's prior improvement experience leading to initial heart failure accreditation. Member hospitals work within four established domains of heart failure: community, hospital, clinicians and science using The Healthcare Colloquium's continuum of care model that leads to:  

·  Integration of heart failure care; from antecedents to early diagnosis and advanced care

·  Streamlined processes across the entire continuum of care beginning in the community

·  Enabling individuals to participate in their own care with more independence and less hospitalization

·  Collaboration with other Colloquium member hospitals across the country

For more information:  www.chifranciscan.org


Related Content

News | Heart Failure

April 16, 2024 — Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally ...

Home April 16, 2024
Home
News | Heart Failure

April 12, 2024 — University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that ...

Home April 12, 2024
Home
News | Heart Failure

April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those ...

Home April 02, 2024
Home
News | Heart Failure

March 29, 2024 — V-Wave announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American ...

Home March 29, 2024
Home
News | Heart Failure

March 25, 2024 — A team of engineers led by the University of Massachusetts Amherst and including colleagues from the ...

Home March 25, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc. , a biotechnology company focused on advancing late-stage cell therapy interventions ...

Home March 15, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc., a biotechnology company focused on advancing late-stage cell therapy interventions for ...

Home March 15, 2024
Home
News | Heart Failure

March 13, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home March 13, 2024
Home
News | Heart Failure

March 8, 2024 — The Texas Heart Institute, Georgia Institute of Technology (Georgia Tech), North Carolina State ...

Home March 08, 2024
Home
News | Heart Failure

March 5, 2024 — FIRE1 announced that it has completed patient enrollment in the U.S. Early Feasibility Study (FUTURE-HF2 ...

Home March 05, 2024
Home
Subscribe Now